Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11684-020-0822-5 http://scihub22266oqcxt.onion/10.1007/s11684-020-0822-5 33017040!7533664!33017040     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Front+Med 2020 ; 14 (6): 746-751 Nephropedia Template TP {{tp|p=33017040|t=2020. Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection |pdf=|usr=}}{{33017040}} gab.com Text Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection JO: Front Med http://www.kidney.de/pget.php?&tw=1&pmid=33017040 #FOAvip The ongoing pandemic of Coronavirus disease 19 (COVID-19) is caused by a newly discovered beta Coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). How long the adaptive immunity triggered by SARS-CoV-2 can last is of critical clinical relevance in assessing the probability of second infection and efficacy of vaccination. Here we examined, using ELISA, the IgG antibodies in serum specimens collected from 17 COVID-19 patients at 6-7 months after diagnosis and the results were compared to those from cases investigated 2 weeks to 2 months post-infection. All samples were positive for IgGs against the S- and N-proteins of SARS-CoV-2. Notably, 14 samples available at 6-7 months post-infection all showed significant neutralizing activities in a pseudovirus assay, with no difference in blocking the cell-entry of the 614D and 614G variants of SARS-CoV-2. Furthermore, in 10 blood samples from cases at 6-7 months post-infection used for memory T-cell tests, we found that interferon gamma-producing CD4(+) and CD8(+) cells were increased upon SARS-CoV-2 antigen stimulation. Together, these results indicate that durable anti-SARS-CoV-2 immunity is common in convalescent population, and vaccines developed from 614D variant may offer protection from the currently predominant 614D variant of SARS-CoV-2. Twit Text FOAVip Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection ????Front Med http://www.kidney.de/pget.php?&tw=1&pmid=33017040 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33017040 #FOAvip English Wikipedia <ref>{{Cite pmid|33017040}}</ref> Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection #MMPMID33017040 Tan Y; Liu F; Xu X; Ling Y; Huang W; Zhu Z; Guo M; Lin Y; Fu Z; Liang D; Zhang T; Fan J; Xu M; Lu H; Chen S Front Med 2020[Dec]; 14 (6): 746-751 PMID33017040show ga The ongoing pandemic of Coronavirus disease 19 (COVID-19) is caused by a newly discovered beta Coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). How long the adaptive immunity triggered by SARS-CoV-2 can last is of critical clinical relevance in assessing the probability of second infection and efficacy of vaccination. Here we examined, using ELISA, the IgG antibodies in serum specimens collected from 17 COVID-19 patients at 6-7 months after diagnosis and the results were compared to those from cases investigated 2 weeks to 2 months post-infection. All samples were positive for IgGs against the S- and N-proteins of SARS-CoV-2. Notably, 14 samples available at 6-7 months post-infection all showed significant neutralizing activities in a pseudovirus assay, with no difference in blocking the cell-entry of the 614D and 614G variants of SARS-CoV-2. Furthermore, in 10 blood samples from cases at 6-7 months post-infection used for memory T-cell tests, we found that interferon gamma-producing CD4(+) and CD8(+) cells were increased upon SARS-CoV-2 antigen stimulation. Together, these results indicate that durable anti-SARS-CoV-2 immunity is common in convalescent population, and vaccines developed from 614D variant may offer protection from the currently predominant 614D variant of SARS-CoV-2. |Adaptive Immunity/*physiology[MESH] |Adult[MESH] |Aged[MESH] |Antibodies, Neutralizing/*blood[MESH] |COVID-19/blood/diagnosis/*immunology[MESH] |Cohort Studies[MESH] |Female[MESH] |Humans[MESH] |Immunoglobulin G/*blood[MESH] |Male[MESH] |Middle Aged[MESH] |SARS-CoV-2/*immunology[MESH] |T-Lymphocytes/*physiology[MESH] |Time Factors[MESH]Durability of neutralizing antibodies and T-cell response post SARS-Co(epmc).pdf DeepDyve Pubget Overpricing